title: Adjuvant therapy in node-negative breast cancer. A panel discussion.
authors.affiliation: University of Texas Health Science Center, San Antonio 78284.
authors.forename: W L
authors.initials: WL
authors.lastname: McGuire
authors.forename: M D
authors.initials: MD
authors.lastname: Abeloff
authors.forename: B
authors.initials: B
authors.lastname: Fisher
authors.forename: J H
authors.initials: JH
authors.lastname: Glick
authors.forename: I C
authors.initials: IC
authors.lastname: Henderson
authors.forename: C K
authors.initials: CK
authors.lastname: Osborne
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004992:Ethics, Medical; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D011379:Prognosis; D011960:Receptors, Estrogen / Q000187:drug effects; D012106:Research; D013629:Tamoxifen / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D011960:Receptors, Estrogen; D013629:Tamoxifen